RU98118019A - PHARMACEUTICAL PREPARATIONS OF Slow-Release, Containing Misolastins - Google Patents
PHARMACEUTICAL PREPARATIONS OF Slow-Release, Containing MisolastinsInfo
- Publication number
- RU98118019A RU98118019A RU98118019/14A RU98118019A RU98118019A RU 98118019 A RU98118019 A RU 98118019A RU 98118019/14 A RU98118019/14 A RU 98118019/14A RU 98118019 A RU98118019 A RU 98118019A RU 98118019 A RU98118019 A RU 98118019A
- Authority
- RU
- Russia
- Prior art keywords
- sustained release
- pharmaceutical preparation
- misolastine
- organic acid
- paragraphs
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims 7
- 230000002459 sustained Effects 0.000 claims 6
- 150000007524 organic acids Chemical class 0.000 claims 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N (+)-tartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- 235000011037 adipic acid Nutrition 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 150000004668 long chain fatty acids Chemical class 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000011044 succinic acid Nutrition 0.000 claims 1
- 150000003444 succinic acids Chemical class 0.000 claims 1
- 239000007939 sustained release tablet Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR96/02662 | 1996-03-04 | ||
FR9602662A FR2745500B1 (en) | 1996-03-04 | 1996-03-04 | SUSTAINED RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING MIZOLASTINE |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98118019A true RU98118019A (en) | 2000-07-20 |
RU2173997C2 RU2173997C2 (en) | 2001-09-27 |
Family
ID=9489799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98118019/14A RU2173997C2 (en) | 1996-03-04 | 1997-02-28 | Retarded-release pharmaceutical preparations including misolastin |
Country Status (35)
Country | Link |
---|---|
US (2) | US6165507A (en) |
EP (1) | EP0906101B1 (en) |
JP (2) | JP2000512617A (en) |
KR (1) | KR100369888B1 (en) |
CN (1) | CN1112929C (en) |
AR (1) | AR006082A1 (en) |
AT (1) | ATE219365T1 (en) |
AU (1) | AU725494B2 (en) |
BG (1) | BG63451B1 (en) |
BR (1) | BR9707827A (en) |
CA (1) | CA2247405C (en) |
CO (1) | CO4780020A1 (en) |
CY (1) | CY2293B1 (en) |
CZ (1) | CZ291418B6 (en) |
DE (1) | DE69713505T2 (en) |
DK (1) | DK0906101T3 (en) |
EE (1) | EE03511B1 (en) |
ES (1) | ES2177942T3 (en) |
FR (1) | FR2745500B1 (en) |
HK (1) | HK1017999A1 (en) |
HU (1) | HU227472B1 (en) |
IL (1) | IL126050A (en) |
IN (1) | IN187739B (en) |
NO (1) | NO315841B1 (en) |
NZ (1) | NZ331947A (en) |
OA (1) | OA10854A (en) |
PL (1) | PL189813B1 (en) |
PT (1) | PT906101E (en) |
RU (1) | RU2173997C2 (en) |
SK (1) | SK282112B6 (en) |
TR (1) | TR199801574T2 (en) |
TW (1) | TW491711B (en) |
UA (1) | UA49004C2 (en) |
WO (1) | WO1997032584A1 (en) |
ZA (1) | ZA971830B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002087960A (en) * | 2000-07-14 | 2002-03-27 | Toyama Chem Co Ltd | Sustained release tablet |
EP1322158B1 (en) * | 2000-10-02 | 2012-08-08 | USV Ltd. | Sustained release pharmaceutical compositions containing metformin and method of their production |
US7052706B2 (en) | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
CA2518442A1 (en) * | 2003-03-04 | 2004-09-16 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
DE10337697A1 (en) * | 2003-08-16 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tablet containing 3 - [(2 - {[4- (hexyloxycarbonylamino-iminomethyl) -phenyl-amino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] - propionic acid ethyl ester or its salts |
BRPI0916689A2 (en) | 2008-07-28 | 2015-11-17 | Takeda Pharmaceutical | stabilized pharmaceutical composition, solid preparation, and methods for stabilizing a pharmaceutical composition, and for stabilizing a solid preparation. |
JP5744412B2 (en) * | 2010-03-26 | 2015-07-08 | テバ製薬株式会社 | Furosemide formulation |
US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364945A (en) * | 1979-12-13 | 1982-12-21 | Whittle Barry J | Nasal composition for relieving nasal distress |
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
FR2587029B1 (en) * | 1985-09-11 | 1987-10-30 | Synthelabo | BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
JPH0776172B2 (en) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | Matrice locks |
JPS62283926A (en) * | 1986-06-02 | 1987-12-09 | Nippon Chemiphar Co Ltd | Long-acting composition of nicardipine hydrochloride |
DE3812799A1 (en) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | ORGANIC PREPARATION FOR THE PURPOSES OF AN ACTUATED ACTIVE INGREDIENTS AND METHOD OF PREPARING THEM |
JP3195391B2 (en) * | 1991-11-14 | 2001-08-06 | エスエス製薬株式会社 | Sustained-release trapidil tablets |
US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
IT1264696B1 (en) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED |
JPH07112932A (en) * | 1993-08-27 | 1995-05-02 | Mitsui Toatsu Chem Inc | Sustained release medicine preparation |
-
1996
- 1996-03-04 FR FR9602662A patent/FR2745500B1/en not_active Expired - Fee Related
-
1997
- 1997-02-27 IN IN358CA1997 patent/IN187739B/en unknown
- 1997-02-27 TW TW086102425A patent/TW491711B/en not_active IP Right Cessation
- 1997-02-28 AU AU19300/97A patent/AU725494B2/en not_active Expired
- 1997-02-28 BR BR9707827A patent/BR9707827A/en not_active IP Right Cessation
- 1997-02-28 AT AT97907145T patent/ATE219365T1/en active
- 1997-02-28 EE EE9800275A patent/EE03511B1/en unknown
- 1997-02-28 DE DE69713505T patent/DE69713505T2/en not_active Expired - Lifetime
- 1997-02-28 IL IL12605097A patent/IL126050A/en not_active IP Right Cessation
- 1997-02-28 SK SK1210-98A patent/SK282112B6/en not_active IP Right Cessation
- 1997-02-28 CO CO97010841A patent/CO4780020A1/en unknown
- 1997-02-28 KR KR10-1998-0706802A patent/KR100369888B1/en active IP Right Grant
- 1997-02-28 CN CN97192804A patent/CN1112929C/en not_active Expired - Lifetime
- 1997-02-28 CZ CZ19982791A patent/CZ291418B6/en not_active IP Right Cessation
- 1997-02-28 DK DK97907145T patent/DK0906101T3/en active
- 1997-02-28 RU RU98118019/14A patent/RU2173997C2/en active
- 1997-02-28 EP EP97907145A patent/EP0906101B1/en not_active Expired - Lifetime
- 1997-02-28 JP JP09531506A patent/JP2000512617A/en active Pending
- 1997-02-28 TR TR1998/01574T patent/TR199801574T2/en unknown
- 1997-02-28 WO PCT/FR1997/000355 patent/WO1997032584A1/en active IP Right Grant
- 1997-02-28 PL PL97328763A patent/PL189813B1/en unknown
- 1997-02-28 PT PT97907145T patent/PT906101E/en unknown
- 1997-02-28 CA CA002247405A patent/CA2247405C/en not_active Expired - Lifetime
- 1997-02-28 UA UA98084447A patent/UA49004C2/en unknown
- 1997-02-28 ES ES97907145T patent/ES2177942T3/en not_active Expired - Lifetime
- 1997-02-28 US US09/125,810 patent/US6165507A/en not_active Expired - Lifetime
- 1997-02-28 HU HU9902458A patent/HU227472B1/en unknown
- 1997-03-03 ZA ZA9701830A patent/ZA971830B/en unknown
- 1997-03-03 AR ARP970100839A patent/AR006082A1/en active IP Right Grant
-
1998
- 1998-08-12 BG BG102692A patent/BG63451B1/en unknown
- 1998-09-02 NO NO19984035A patent/NO315841B1/en not_active IP Right Cessation
- 1998-09-04 OA OA9800160A patent/OA10854A/en unknown
- 1998-09-18 NZ NZ331947A patent/NZ331947A/en not_active IP Right Cessation
-
1999
- 1999-06-30 HK HK99102759A patent/HK1017999A1/en not_active IP Right Cessation
-
2002
- 2002-08-26 CY CY0200052A patent/CY2293B1/en unknown
-
2005
- 2005-01-03 US US11/027,680 patent/US20050202089A1/en not_active Abandoned
-
2007
- 2007-03-05 JP JP2007054262A patent/JP2007182451A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98118019A (en) | PHARMACEUTICAL PREPARATIONS OF Slow-Release, Containing Misolastins | |
NZ322467A (en) | Use of epinastine in the treatment of pain | |
RU2006128796A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SIDE EFFECTS AND IDIOPATHIC SYNDROMES Caused by OPIOIDES | |
NZ515911A (en) | Implantable gel compositions and method of manufacture | |
CA2191645A1 (en) | Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders | |
CA2149242A1 (en) | Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders | |
AU2681300A (en) | Solid oral dosage form containing an enhancer | |
EP0668073A3 (en) | Polyester matrix for a pharmaceutical sustained-release preparation. | |
HUT53634A (en) | Herbicides comprising aromatic carboxylic acid derivatives as active ingredient and process for producing the active ingredients | |
RU94046413A (en) | Pharmaceutical composition containing cyclosporine derivative and its preparing | |
RU93004860A (en) | HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION, USE AND PHARMACEUTICAL COMPOSITION | |
JP2007182451A (en) | Sustained-release pharmaceutical formulation containing mizolastine | |
CA2366841A1 (en) | Tolperisone-containing pharmaceutical preparation for oral administration | |
RU93058535A (en) | TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT | |
CA2255052A1 (en) | Sustained release preparation of prostaglandin i derivatives | |
NO177774C (en) | Process for the preparation of a composition suitable for administration of a substantially water-insoluble active ingredient | |
EE9700078A (en) | Pyrimido (1,2-a) indoles, process for their preparation, use in the manufacture of medicaments, medicaments containing these indoles and carboxylic acids used in the manufacture of indoles and method for their preparation | |
JP2752792B2 (en) | Novel composition containing selegiline | |
RU93054754A (en) | 6-HETEROCYCLO-4-AMINO-1,3,4,5-TETRAHYDROBENZ / CD / INDOLS, THEIR APPLICATION FOR THE TREATMENT OF SUSPENSION AND MORPHANIZED PHENOMENA, PHARMACEUTICAL COMPOSITION, THE METHOD OF THEIR | |
HUT54106A (en) | Process for producing carboxylic acid amides and pharmaceutical compositions comprising such active ingredient | |
CA2186767A1 (en) | Fractionation of triglyceride oils | |
RU92016533A (en) | Arylalkyl ethers of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene carboxylic acid possessing therapeutic activity, method for their preparation, pharmaceutical composition | |
CA2223695A1 (en) | Dicarboxylic acids as an animal feed ingredient | |
HUT47124A (en) | Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients | |
HUT52388A (en) | Process for producing pharmaceutical compositions comprising unsaturated fatty acids and selenium as active ingredient |